GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » Equity-to-Asset

Targeted Medical Pharma (Targeted Medical Pharma) Equity-to-Asset : -5.31 (As of Dec. 2015)


View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Targeted Medical Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2015 was $-12.90 Mil. Targeted Medical Pharma's Total Assets for the quarter that ended in Dec. 2015 was $2.43 Mil. Therefore, Targeted Medical Pharma's Equity to Asset Ratio for the quarter that ended in Dec. 2015 was -5.31.

The historical rank and industry rank for Targeted Medical Pharma's Equity-to-Asset or its related term are showing as below:

TRGM's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.59
* Ranked among companies with meaningful Equity-to-Asset only.

Targeted Medical Pharma Equity-to-Asset Historical Data

The historical data trend for Targeted Medical Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Targeted Medical Pharma Equity-to-Asset Chart

Targeted Medical Pharma Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Equity-to-Asset
Get a 7-Day Free Trial 0.07 -0.19 -1.40 -3.99 -5.31

Targeted Medical Pharma Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.99 -4.15 -5.05 -5.04 -5.31

Competitive Comparison of Targeted Medical Pharma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Targeted Medical Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Targeted Medical Pharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Targeted Medical Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Targeted Medical Pharma's Equity-to-Asset falls into.



Targeted Medical Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Targeted Medical Pharma's Equity to Asset Ratio for the fiscal year that ended in Dec. 2015 is calculated as

Equity to Asset (A: Dec. 2015 )=Total Stockholders Equity/Total Assets
=-12.895/2.427
=-5.31

Targeted Medical Pharma's Equity to Asset Ratio for the quarter that ended in Dec. 2015 is calculated as

Equity to Asset (Q: Dec. 2015 )=Total Stockholders Equity/Total Assets
=-12.895/2.427
=-5.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Targeted Medical Pharma  (OTCPK:TRGM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Targeted Medical Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Targeted Medical Pharma (Targeted Medical Pharma) Business Description

Traded in Other Exchanges
N/A
Address
2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077
Targeted Medical Pharma Inc is a United States based specialty pharmaceutical company, which develops and commercializes amino acid-based medications. The business activities of the group are functioned through Targeted Medical Pharma; Complete Claims Processing, Inc. and Amino Nutritionals segments. The operations of the group are primarily functioned through the region of United States and it derives the majority of revenue from Targeted Medical Pharma segment which develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers through employed sales representatives, independent distributors, and pharmacies.
Executives
William B. Horne officer: Chief Financial Officer C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald director C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb director MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph officer: See Remarks C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour director, 10 percent owner, officer: Former President C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher director 12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke officer: Chief Financial Officer C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc 10 percent owner, other: Former 10% Owner 269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel director, officer: Vice President 16178 EAST PRETENCE PLZ, AURORA CO 80015

Targeted Medical Pharma (Targeted Medical Pharma) Headlines

No Headlines